Business2 weeks ago
Viking Therapeutics Achieves Promising Results in GLP-1 Drug Race
Viking Therapeutics, Inc. has emerged as a strong contender in the expanding market for oral GLP-1 obesity drugs, following impressive Phase 2 trial results for its...
